Lithium Hexamethyldisilazide → N-(5-chloro-3-(2-methyl-9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-yl)pyridin-2-yl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-4-amine

HRID 1621433

Reaktionsgleichung

Reaktionsgleichung von HRID 1621433
[Cl:1][C:2]1[CH:3]=[C:4]([C:9]2[N:17]=[C:16]([CH3:18])[N:15]=[C:14]3[C:10]=2[N:11]=[CH:12][N:13]3[CH:19]2[CH2:24][CH2:23][CH2:22][CH2:21][O:20]2)[C:5](F)=[N:6][CH:7]=1.[O:25]1[CH2:30][CH2:29][CH2:28][CH2:27][CH:26]1[N:31]1[C:39]2[CH:38]=[CH:37][CH:36]=[C:35]([NH2:40])[C:34]=2[CH:33]=[N:32]1.[Li+].C[Si]([N-][Si](C)(C)C)(C)C>C1COCC1>[Cl:1][C:2]1[CH:3]=[C:4]([C:9]2[N:17]=[C:16]([CH3:18])[N:15]=[C:14]3[C:10]=2[N:11]=[CH:12][N:13]3[CH:19]2[CH2:24][CH2:23][CH2:22][CH2:21][O:20]2)[C:5]([NH:40][C:35]2[C:34]3[CH:33]=[N:32][N:31]([CH:26]4[CH2:27][CH2:28][CH2:29][CH2:30][O:25]4)[C:39]=3[CH:38]=[CH:37][CH:36]=2)=[N:6][CH:7]=1

Komponenten

5

Edukt 3

HCID 2733832Lithium HexamethyldisilazideHCID 441182321-(Oxan-2-yl)-1H-indazol-4-amineHCID 595482256-(5-chloro-2-fluoropyridin-3-yl)-2-methyl-9-(tetrahydro-2H-pyran-2-yl)-9H-purine

Produkt 1

HCID 59548169N-(5-chloro-3-(2-methyl-9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-yl)pyridin-2-yl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-4-amineAusbeute 82 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 8028TetrahydrofuranLösungsmittel2×

Versuchsvorschrift

A solution of 6-(5-chloro-2-fluoropyridin-3-yl)-2-methyl-9-(tetrahydro-2H-pyran-2-yl)-9H-purine (75.3 mg, 217 μmol) and 1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-4-amine (49.4 mg, 227 μmol) in THF (1.0 mL) was cooled in an ice bath and treated dropwise with LiHMDS in THF (0.68 mL of 1.0 M solution, 3 equiv.) giving a deep red solution. The mixture was stirred for 45 min and then quenched with water (0.1 mL). Extraction into EtOAc from saturated aqueous NaHCO3, drying (MgSO4) and concentration gave a deep yellow oil. Purification by flash chromatography on silica eluting with 40% EtOAc/hexane gave N-(5-chloro-3-(2-methyl-9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-yl)pyridin-2-yl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-4-amine (96.8 mg, 82.0% yield) (yellow band on column) as a bright yellow solid. 1H NMR (400 MHz, CDCl3) δ 12.70 (br. s., 1H); 9.82 (d, J=2.74 Hz, 1H); 8.21-8.40 (m, 3H); 8.06 (dd, J=7.53, 1.66 Hz, 1H); 7.42 (t, J=8.02 Hz, 1H); 7.20-7.30 (m, 1H); 5.87 (dd, J=10.47, 2.25 Hz, 1H); 5.72 (dd, J=9.59, 2.54 Hz, 1H); 4.15-4.28 (m, 1H); 4.02-4.12 (m, 1H); 3.70-3.88 (m, 2H); 3.00 (s, 3H); 2.52-2.71 (m, 1H); 1.98-2.27 (m, 5H); 1.58-1.92 (m, 6H). m/z (ESI, +ve) 545.1 (M+H)+.

Aufarbeitung

  1. customgiving a deep red solution
  2. customquenched with water (0.1 mL)
  3. extractionExtraction into EtOAc from saturated aqueous NaHCO3
  4. customdrying
  5. concentration(MgSO4) and concentration
  6. customgave a deep yellow oil
  7. customPurification by flash chromatography on silica eluting with 40% EtOAc/hexane

Quellen und Nachweise

ORD-Eintrag
ord-c4d3c34103824ff686fdef3fcc6f3a8d
Quelldatensatz
uspto-grants-2014_07
Patentnummer
US08772480B2

Verknüpfte Notizen

Wird geladen…